DeepHealth
Financiado
Deep Learning and HPC to Boost Biomedical Applications for Health
Health scientific discovery and innovation are expected to quickly move forward under the so called fourth paradigm of science, which relies on unifying the traditionally separated and heterogeneous high-performance computing and...
Health scientific discovery and innovation are expected to quickly move forward under the so called fourth paradigm of science, which relies on unifying the traditionally separated and heterogeneous high-performance computing and big data analytics environments.
Under this paradigm, the DeepHealth project will provide HPC computing power at the service of biomedical applications; and apply Deep Learning (DL) techniques on large and complex biomedical datasets to support new and more efficient ways of diagnosis, monitoring and treatment of diseases.
DeepHealth will develop a flexible and scalable framework for the HPC + Big Data environment, based on two new libraries: the European Distributed Deep Learning Library (EDDLL) and the European Computer Vision Library (ECVL). The framework will be validated in 14 use cases which will allow to train models and provide training data from different medical areas (migraine, dementia, depression, etc.). The resulting trained models, and the libraries, will be integrated and validated in 7 existing biomedical software platforms, which include: a) commercial platforms (e.g. PHILIPS Clinical Decision Support System from or THALES SIX PIAF; and b) research oriented platforms (e.g. CEA`s ExpressIF™ or CRS4`s Digital Pathology). Impact is measured by tracking the time-to-model-in-production (ttmip).
Through this approach, DeepHealth will also standardise HPC resources to the needs of DL applications, and underpin the compatibility and uniformity on the set of tools used by medical staff and expert users. The final DeepHealth solution will be compatible with HPC infrastructures ranging from the ones in supercomputing centers to the ones in hospitals.
DeepHealth involves 21 partners from 9 European Countries, gathering a multidisciplinary group from research organisations (9), health organisations (4) as well as (4) large and (4) SME industrial partners, with strong commitment towards innovation, exploitation and sustainability.
ver más
Duración del proyecto: 42 meses
Fecha Inicio: 2018-12-05
Fecha Fin: 2022-06-30
Fecha Fin: 2022-06-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2022-06-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
Presupuesto
El presupuesto total del proyecto asciende a
15M€
Líder del proyecto
EVERIS SPAIN
Realizar la actividad de compra, suscripcion permuta tenencia y venta de valores mobiliarios acciones o participaciones nacionales o extranj...
Perfil tecnológico
TRL
4-5
9M
Perfil tecnológico
TRL
4-5
9M
136.25K€ |
Participante